Cameron Durrant, MD, MBA

Chairman and CEO

  • Senior pharmaceutical and biotech exec, turnaround specialist
  • Senior exec roles at Pharmacia/Pfizer, J+J in US, Merck, GSK in Europe; experience as Exec Chairman, CEO and CFO; CEO roles at three specialty pharma groups
  • Expertise in anti-infectives, pediatrics, oncology

Greg Jester

Chief Financial Officer

  • Decades of financial, operational and entrepreneurial experience in life sciences
  • Vice president, finance, for privately held Tris Pharma, Inc
  • CFO roles at private and publicly owned pharmaceutical companies, including Alvogen and Innovive

Tarek Sahmoud, MD, PhD

Chief Medical Officer

  • 25+ years oncology drug development, medical, regulatory affairs experience
  • Novartis CAR-T clinical development consultant; former Novartis VP, Senior Global Clinical Program Head (oncology); senior development roles at Celgene, Bristol-Myers Squibb and Boehringer-Ingelheim
  • Registered Arimidex, Afinitor; responsibility for Kymriah, Yervoy, Abraxane, marizomib, dasatinib